New Drug: Loncastuximab tesirine for relapsed/refractory DLBCL
|New Drug: Loncastuximab tesirine for relapsed/refractory DLBCL|
Blood. Nov 2020. 136 (Supplement 1):35-37
Caimi PF, et al. Efficacy and Safety of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Diffuse Large B-Cell Lymphomahttps://doi.org/10.1182/blood-2020-137524
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.